We are live on ! Find out more
SONM icon

DNA X Inc
SONM

13 hedge funds and large institutions have $435K invested in DNA X Inc in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.06% less ownership

Funds ownership: 0.08% → 0.01% (-0.06%)

19% less funds holding

Funds holding: 16 → 13 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

78% less capital invested

Capital invested by funds: $2M → $435K (-$1.56M)

Holders
13
Holders Change
-3
Holders Change %
-18.75%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
+$166K
2
E
Ergoteles
New York
+$18.8K
3
Citigroup
Citigroup
New York
+$18.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$15.3K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$135

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$976K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$246K
3
QC
Quadrature Capital
United Kingdom
-$112K
4
Renaissance Technologies
Renaissance Technologies
New York
-$66.1K
5
CS
Credit Suisse
Switzerland
-$55K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
1
Bank of New York Mellon
New York
$189K +$166K +1,226 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$53K – – –
SFI
3
Susquehanna Fundamental Investments
Pennsylvania
$50K – – –
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$43K +$15.3K +113 +69%
Citigroup
5
Citigroup
New York
$34K +$18.3K +135 +163%
Renaissance Technologies
6
Renaissance Technologies
New York
$21K -$66.1K -488 -78%
E
7
Ergoteles
New York
$21K +$18.8K +139 New
TSS
8
Two Sigma Securities
New York
$17K -$16.4K -121 -52%
TRCT
9
Tower Research Capital (TRC)
New York
$6K +$135 +1 +3%
Morgan Stanley
10
Morgan Stanley
New York
$1K -$976K -7,205 -100%
Vanguard Group
11
Vanguard Group
Pennsylvania
– -$246K -1,488 Closed
QC
12
Quadrature Capital
United Kingdom
– -$112K -675 Closed
CS
13
Credit Suisse
Switzerland
– -$55K -333 Closed
VF
14
Virtu Financial
New York
– -$47K -286 Closed
Jane Street
15
Jane Street
New York
– -$21K -126 Closed
Two Sigma Advisers
16
Two Sigma Advisers
New York
– -$19K -117 Closed
Fidelity Investments
17
Fidelity Investments
Massachusetts
– +$135 +1 New

SONM Hedge Fund Activity: Q1 2022 in Review

13 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q1 2022, worth a combined $435K — down 78% from $2M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of SONM and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $166K. The largest seller was Morgan Stanley, cutting an estimated $976K.

  • 13 institutional investors held DNA X Inc (SONM) as of Q1 2022, down from 16 in Q4 2021.
  • Funds reported $435K of DNA X Inc stock for Q1 2022, down 78% quarter-over-quarter.
  • 3 funds opened new DNA X Inc positions in Q1 2022 and 6 closed out, a net change of -3 holders.
  • The largest DNA X Inc buyer in Q1 2022 was Bank of New York Mellon, an estimated $166K added.
  • The largest DNA X Inc seller in Q1 2022 was Morgan Stanley, an estimated $976K sold.

Based on aggregated 13F filings for Q1 2022.